Chemoinformaics analysis of METHYL 8-OXOOCTADEC-9-YNOATE
| Molecular Weight | 308.462 | nRot | 13 |
| Heavy Atom Molecular Weight | 276.206 | nRig | 3 |
| Exact Molecular Weight | 308.235 | nRing | 0 |
| Solubility: LogS | -5.87 | nHRing | 0 |
| Solubility: LogP | 5.679 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 55.4734 |
| nHD | 0 | BPOL | 35.5746 |
| QED | 0.212 |
| Synth | 2.447 |
| Natural Product Likeliness | 0.666 |
| NR-PPAR-gamma | 0.504 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.98 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.623 |
| MDCK | 0.0000201 |
| BBB | 0.515 |
| PPB | 0.980562 |
| VDSS | 1.186 |
| FU | 0.00903165 |
| CYP1A2-inh | 0.616 |
| CYP1A2-sub | 0.429 |
| CYP2c19-inh | 0.799 |
| CYP2c19-sub | 0.189 |
| CYP2c9-inh | 0.625 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.068 |
| CYP3a4-inh | 0.698 |
| CYP3a4-sub | 0.065 |
| CL | 6.85 |
| T12 | 0.411 |
| hERG | 0.037 |
| Ames | 0.263 |
| ROA | 0.034 |
| SkinSen | 0.963 |
| Carcinogencity | 0.374 |
| EI | 0.911 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.258 |
| Antiviral | Yes |
| Prediction | 0.525443 |